Constipation
Drug research and approvals for constipation: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 18, 2026, 100 studies of constipation are recruiting on ClinicalTrials.gov, Health Canada has authorized 17 drug trials for it since 2013, FDA has 0 approved and 2 open orphan designations naming it, and the EU has 5 authorised medicines for it.
- Recruiting worldwide: 100
- Trials authorized in Canada: 17
- FDA orphan approvals: 0
- EU medicines: 5
Recruiting Now
Newest start dates first, of 100 recruiting on ClinicalTrials.gov ↗- Effect of a Constipation Prevention Checklist in Hip Surgery PatientsNCT07895316 · Not applicable · Cumhuriyet University · starts Oct 12, 2026
- Outcome Research in Bowel Irrigation Techniques for the Treatment of Chronic Constipation and/or Faecal IncontinenceNCT07473622 · Not applicable · Qufora A/S · starts Oct 9, 2026
- Core-Based Movement and Nutritional Counselling for Stress and Metabolic Outcomes in Overweight Women With Functional…NCT07694830 · Not applicable · Cairo University · starts Oct 4, 2026
- Relationship Between Interoception and Postural Control in Constipation-Predominant Irritable Bowel SyndromeNCT07870915 · Not reported · Saglik Bilimleri Universitesi · starts Oct 1, 2026
- Effect of Abdominal Massage Training Provided to Caregivers on Constipation ManagementNCT07886125 · Not applicable · HAMİYET KIZIL · starts Sep 9, 2026
- Comparison of a New Non-invasive Device With the Invasive Gold-standard Investigation to Assess Function of the Large…NCT07789782 · Not applicable · Murdoch Childrens Research Institute · starts Sep 2, 2026
- Probiotics Improve ConstipationNCT07765004 · Not applicable · Wecare Probiotics Co., Ltd. · starts Aug 7, 2026
- Radicle GI HealthTM VNB: A Study Assessing the Impact of Health and Wellness Products on Constipation and Related…NCT07713810 · Not applicable · Radicle Science · starts Jul 30, 2026
- Adults With ConstipationNCT07529457 · Not applicable · Wecare Probiotics Co., Ltd. · starts Jul 24, 2026
- IBS-Oriented CDED Versus Low FODMAP Diet for Irritable Bowel SyndromeNCT07707635 · Not applicable · Ariel University · starts Jul 19, 2026
Drug Pipeline
31 approved, 10 in phase 3, 16 in phase 2, 8 in phase 1 or earlier; from ChEMBL's drug indications, furthest stage reached for this conditionApproved: Prucalopride, Lubiprostone, Naloxegol, Polyethylene glycol 3350, Methylnaltrexone, Polyethylene glycol, Plecanatide, Bisacodyl, Senna, Linaclotide, Tegaserod, Lactulose, Docusate, Alvimopan, Naldemedine, Naloxone, Glycerin, Picosulfuric acid, Mannitol, Magnesium oxide, Sorbitol, Tenapanor, Oxyphenisatine, Phenolphthalein, Danthron, Sodium phosphate, dibasic, anhydrous, Lactitol, Methylcellulose, Cascara sagrada, Castor oil, Mineral oil
- Bevenopran
- Phase 3 Mu opioid receptor antagonist
- Elobixibat
- Phase 3 Ileal bile acid transporter inhibitor
- Maltodextrin
- Phase 3
- Mosapride
- Phase 3 Serotonin 3 (5-HT3) receptor antagonist
- Polyethylene glycol 4000
- Phase 3 Laxative
- Pectin
- Phase 3
- Simeticone
- Phase 3 Anti-gas, surfactant
- Acesulfame
- Phase 3
- Konjac mannan
- Phase 3
- Wheat bran
- Phase 3
- Axelopran
- Phase 2 Mu opioid receptor antagonist
- Methylsamidorphan
- Phase 2 Mu opioid receptor antagonist
- Lactobacillus acidophilus
- Phase 2 Probiotic
- Relenopride
- Phase 2 Serotonin 4 (5-HT4) receptor agonist
- Hydromorphone
- Phase 2 Mu opioid receptor agonist
- Vancomycin
- Phase 2 Peptidoglycan inhibitor
- Alfuzosin
- Phase 2 Adrenergic receptor alpha-1 agonist
- Octreotide
- Phase 2 Somatostatin receptor agonist
- Pradigastat
- Phase 2 Diacylglycerol O-acyltransferase 1 inhibitor
- Itopride
- Phase 2 Dopamine D2 receptor antagonist
- Dolcanatide
- Phase 2 Heat-stable enterotoxin receptor agonist
- Alcohol
- Phase 2
- Psyllium husk
- Phase 2
- Propylene glycol
- Phase 2
- TU-100
- Phase 2
- Bisoxatin acetate
- Phase 2
- Codeine
- Phase 1 Opioid receptors; mu/kappa/delta agonist
- Morphine
- Phase 1 Mu opioid receptor agonist
- Moxifloxacin
- Phase 1 Topoisomerase IV inhibitor
- Quinidine
- Phase 1 Sodium channel alpha subunit blocker
Showing the 30 furthest along of 34 in trials.
How Its Trials Ended
967 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 247 whose ending is known, 58% met their primary endpoint, 6% missed it and 35% stopped early.
- Completed, result not reported45847%
- Met its primary endpoint14415%
- Ongoing13714%
- Status unknown12513%
- Stopped: other or unclear515%
- Stopped: enrollment or feasibility202%
- Missed its primary endpoint162%
- Stopped: sponsor or business decision81%
- Stopped: lack of efficacy40%
- Stopped: funding30%
- Stopped: safety10%
Trials Authorized in Canada
The 10 newest of 17; search them all in Canada trials| Jul 7, 2020 | A phase 2, randomized, double-blind, placebo-controlled, sequential, ascending, multidose study to evaluate the safety and efficacy of linaclotide in pediatric…Constella (linaclotide) | AbbVie | Closed |
| Mar 5, 2020 | A phase 3, open-label, long-term safety study of oral linaclotide administered to pediatric participants with functional constipation (fc) or irritable bowel…Linaclotide (constella) | AbbVie | Ongoing |
| Oct 24, 2019 | A phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group, safety and efficacy study of linaclotide administered orally to children,…Linaclotide | AbbVie | Closed |
| Dec 30, 2015 | Implementation of high-resolution manometry (hrcm) to improve the care of children with refractory chronic constipationprucalopride/ bisacodyl | Hamilton Health Sciences Corporation | Pending |
| Dec 8, 2015 | A multicenter, randomized, double-blind, placebo-controlled, parallel group, safety and efficacy study of a range of linaclotide doses administered orally to…Linaclotide | Forest Research Institute | Closed |
| Dec 8, 2015 | A multicenter, randomized, double-blind, placebo-controlled, parallel group, safety and efficacy study of a range of linaclotide doses administered orally to…Linaclotide | Forest Research Institute | Closed |
| May 14, 2014 | A multicentre, long-term safety, efficacy and pharmacokinetics study of lubiprostone in paediatric subjects aged >=6 to <18 years with functional constipationAmitiza (lubiprostone) | Mallinckrodt | Closed |
| Mar 12, 2014 | A multicentre, randomised, placebo-controlled, double-blinded study of the efficacy, safety, and pharmacokinetics of lubiprostone in paediatric subjects aged >…Lubiprostone | Mallinckrodt | Closed |
| Mar 7, 2014 | An open-label extension (ole), long-term safety and tolerability study of plecanatide in patients with chronic idiopathic constipation (cic)Plecanatide | Synergy Pharmaceuticals Inc | Ongoing |
| Mar 7, 2014 | A randomized, 12-week, double-blind, placebo-controlled study to assess the safety and efficacy of plecanatide (3.0 and 6.0 mg) in patients with chronic…Plecanatide | Synergy Pharmaceuticals Inc | Closed |
FDA Orphan Designations
Approved first, then open designations, newest first| Sep 16, 2002 | Human gammaglobulinTreatment of gastrointestinal disturbances (to include constipation, diarrhea, and abdominal pain) associated with regression-onset autism… | Latona Life Sciences, Inc. | Designated |
| Jun 17, 1996 | MethylnaltrexoneTreatment of chronic opioid-induced constipation unresponsive to conventional therapy. | Progenics Pharmaceuticals, Inc. | Designated |
Medicines Authorised in the EU
Newest first| Feb 18, 2019 | RizmoicNaldemedine | Shionogi B.V. | EMA ↗ |
| Dec 7, 2014 | MoventigNaloxegol | Grunenthal GmbH | EMA ↗ |
| Nov 26, 2012 | ConstellaLinaclotide | AbbVie Deutschland GmbH & Co. KG | EMA ↗ |
| Oct 14, 2009 | ResolorPrucalopride | Takeda Pharmaceuticals International AG Ireland | EMA ↗ |
| Jul 1, 2008 | RelistorMethylnaltrexone bromide | Bausch Health Ireland Limited | EMA ↗ |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA